Incidence of XXXX in New Brunswick, Canada, 1992 to 2001.

@entity1 @entity5 @entity1489 @entity957 @entity1491
BACKGROUND: @entity1491 ( @entity1491 ) and @entity957 ( @entity957 ), collectively referred to as @entity1489 ( @entity1489 ), cause significant morbidity and generate a substantial cost to the health care system. Canadian data on the incidence of @entity1489 are lacking. OBJECTIVE: To study the incidence and characteristics of @entity1489 in New Brunswick, Canada (population 729,498 @entity1 in 2001), by using the Provincial @entity5 Registry. METHOD: Data were obtained from 1992 to 2001 from the New Brunswick Provincial @entity5 Registry, to which reporting of all @entity5 is mandatory. @entity5 of a given histologic type are recorded only once in the registry per individual per lifetime. A descriptive analysis of incidence rates of @entity1491 and invasive @entity957 of the skin was performed in relation to gender, age, and anatomic location. The main outcome measures were the age- and sex-specific incidence rates of @entity1491 and @entity957 . Age standardization was performed using the Canadian, US, and world standard populations. RESULTS: When adjusted to the world standard population, the age-standardized incidence rates (ASIRs) per 100,000 population for @entity1491 from 1992 through 2001 were 87 for males and 68 for females. For invasive @entity957 , the ASIRs per 100,000 population were 34 for males and 16 for females. There was an increasing incidence trend for both @entity1491 and invasive @entity957 over the 10-year study period, with minimal change in the incidence of @entity957 in @entity1 . The overall ratio of @entity1491 to invasive @entity957 in the population was 2.8 to 1. The approximate lifetime probabilities of developing @entity1491 and invasive @entity957 were 13% and 5%, respectively. CONCLUSIONS: The incidence of @entity1489 in the province of New Brunswick is similar to that reported from 1973 through 1987 in the province of British Columbia, higher than those reported in most parts of Europe, and lower than all published rates in the United States and Australia. Owing to the inability of the registry to account for @entity5 multiplicity, the actual annual number of all @entity1489 lesions in this population is likely much higher.
